Diana M. Sobieraj
Associate Professor/Pharmacy Practice
Storrs Mansfield
Are you Diana M. Sobieraj?
How to update your information.
Scholarly Contributions
178 Scholarly Contributions
Impact of rivarixaban on the inpatient treatment of venous thromboembollism
2014
Research Type: Poster/Presentation
Indirect treatment comparison of new oral nticoagulants for the treatment of venous thromboembolism
2014
Research Type: Poster/Presentation
Characteristics and Quality of Echocardiography Laboratories in the United States: Insights from the Intersocietal Accreditation Comission
2014
Research Type: Poster/Presentation
Cancer screening certificate program: a review of diagnostic test statistics
2014
Research Type: Poster/Presentation
Credentials of staff performing echocardiography in the United States: Hospital and Non-hospital based laboratory differ in their staff
2014
Research Type: Poster/Presentation
Nutritional supplements to reduce cardiovascular events- whhere is the evidence?
2014
Research Type: Poster/Presentation
Cardiovasular effects of pharmacologic therapies for smoking cessation
2013
Research Type: Journal Article
The cost-effectiveness of oral factor Xa inhibitors compared with enoxaparin for the prevention of venous thromboembolism in total hip or knee replacement surgery
2013
Research Type: Journal Article
Methods used to conduct and report Bayesian mixed treatment comparisons published in the medical literature: a systematic review.
2013
Research Type: Journal Article
Comparative effectiveness of combined pharmacologic and mechanical thromboprophylaxis versus either method alone in major orthopedic surgery: a systematic review and meta-analysis.
2013
Research Type: Journal Article
Comparative effectiveness of combined pharmacologic and mechanical thromboprophylaxis versus either method alone in major orthopedic surgery A systematic review and metaanalysis
2013
Research Type: Journal Article
Basal insulin titration to improve glycemic control for patients with diabetes
2013
Research Type: Other Scholarly Work
First drug approved specifically for multi-drug resistant tuberculosis
2013
Research Type: Other Scholarly Work